Found: 146
Select item for more details and to access through your institution.
A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: prolongation of prostate-specific antigen doubling time.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Immune responses in patients with esophageal cancer treated with SART1 peptide-pulsed dendritic cell vaccine.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 4, p. 1699, doi. 10.3892/ijo.2015.2846
- By:
- Publication type:
- Article
Feasibility study of personalized peptide vaccination for advanced non-small cell lung cancer patients who failed two or more treatment regimens.
- Published in:
- International Journal of Oncology, 2015, v. 46, n. 1, p. 55, doi. 10.3892/ijo.2014.2699
- By:
- Publication type:
- Article
A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.
- Published in:
- BJU International, 2011, v. 108, n. 6, p. 831, doi. 10.1111/j.1464-410X.2010.09933.x
- By:
- Publication type:
- Article
Comparison of Claudin 18.2 expression in primary tumors and lymph node metastases in Japanese patients with gastric adenocarcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2019, v. 49, n. 9, p. 870, doi. 10.1093/jjco/hyz068
- By:
- Publication type:
- Article
DAB<sub>486</sub>IL-2 (IL-2 Toxin) Selectively Inactivates High-Affinity IL-2 Receptor-Bearing Human Peripheral Blood Mononuclear Cells.
- Published in:
- Annals of the New York Academy of Sciences, 1991, v. 636, n. 1, p. 403, doi. 10.1111/j.1749-6632.1991.tb33479.x
- By:
- Publication type:
- Article
A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles.
- Published in:
- Journal of Medical Virology, 2009, v. 81, n. 7, p. 1232, doi. 10.1002/jmv.21518
- By:
- Publication type:
- Article
Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase II Study of Personalized Peptide Vaccination with Both a Hepatitis C Virus-Derived Peptide and Peptides from Tumor-Associated Antigens for the Treatment of HCV-Positive Advanced Hepatocellular Carcinoma Patients.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Analysis of tumor necrosis factor-α production and polymorphisms of the tumor necrosis factor-α gene in individuals with a history of Kawasaki disease.
- Published in:
- Pediatrics International, 1999, v. 41, n. 4, p. 341, doi. 10.1046/j.1442-200X.1999.01085.x
- By:
- Publication type:
- Article
Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt–Koyanagi–Harada disease.
- Published in:
- International Immunology, 1996, v. 8, n. 5, p. 799, doi. 10.1093/intimm/8.5.799
- By:
- Publication type:
- Article
Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 3, p. 459, doi. 10.1002/(SICI)1097-0215(19990505)81:3<459::AID-IJC21>3.0.CO;2-6
- By:
- Publication type:
- Article
A newly identified MAGE-3-derived epitope recognized by HLA-A24-restricted cytotoxic T lymphocytes.
- Published in:
- International Journal of Cancer, 1999, v. 81, n. 3, p. 387, doi. 10.1002/(SICI)1097-0215(19990505)81:3<387::AID-IJC12>3.0.CO;2-Z
- By:
- Publication type:
- Article
Expression of the SART-1 tumor rejection antigen in breast cancer.
- Published in:
- International Journal of Cancer, 1999, v. 80, n. 1, p. 64, doi. 10.1002/(SICI)1097-0215(19990105)80:1<64::AID-IJC13>3.0.CO;2-7
- By:
- Publication type:
- Article
HLA class-I-restricted and tumor-specific CTL in tumor-infiltrating lymphocytes of patients with gastric cancer.
- Published in:
- International Journal of Cancer, 1997, v. 70, n. 6, p. 631, doi. 10.1002/(SICI)1097-0215(19970317)70:6<631::AID-IJC1>3.0.CO;2-W
- By:
- Publication type:
- Article
Detection of MAGE-4 protein in sera of patients with head-and-neck squamous-cell carcinoma.
- Published in:
- International Journal of Cancer, 1997, v. 70, n. 3, p. 287, doi. 10.1002/(SICI)1097-0215(19970127)70:3<287::AID-IJC7>3.0.CO;2-T
- By:
- Publication type:
- Article
A monoclonal antibody KIS-1 recognizing a new membrane antigen on human squamous-cell carcinoma.
- Published in:
- International Journal of Cancer, 1996, v. 66, n. 5, p. 600, doi. 10.1002/(SICI)1097-0215(19960529)66:5<600::AID-IJC3>3.0.CO;2-X
- By:
- Publication type:
- Article
Expression of MAGE-1, MAGE-2, MAGE-3/-6 and MAGE-4A/-4B genes in ovarian tumors.
- Published in:
- International Journal of Cancer, 1995, v. 64, n. 6, p. 388, doi. 10.1002/ijc.2910640607
- By:
- Publication type:
- Article
Expression of the MAGE gene family in human head-and-neck squamous-cell carcinomas.
- Published in:
- International Journal of Cancer, 1995, v. 64, n. 5, p. 304, doi. 10.1002/ijc.2910640504
- By:
- Publication type:
- Article
Detection of mage-4 protein in lung cancers.
- Published in:
- International Journal of Cancer, 1995, v. 64, n. 3, p. 158, doi. 10.1002/ijc.2910640303
- By:
- Publication type:
- Article
Polyclonal uses of T-cell receptor (TCR)α and β genes for cytotoxic T lymphocytes in human metastatic melanoma: possible involvement of TCRα in tumor-cell recognition.
- Published in:
- International Journal of Cancer, 1994, v. 58, n. 4, p. 497, doi. 10.1002/ijc.2910580407
- By:
- Publication type:
- Article
Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma.
- Published in:
- International Journal of Cancer, 1994, v. 58, n. 3, p. 317, doi. 10.1002/ijc.2910580302
- By:
- Publication type:
- Article
Human renal-cell carcinoma cells are able to activate natural killer cells.
- Published in:
- International Journal of Cancer, 1992, v. 51, n. 2, p. 290, doi. 10.1002/ijc.2910510219
- By:
- Publication type:
- Article
Effects of HC antibody in autologous tumor-specific cytotoxicity by human melanoma tumor-infiltrating lymphocytes.
- Published in:
- International Journal of Cancer, 1991, v. 49, n. 3, p. 356, doi. 10.1002/ijc.2910490307
- By:
- Publication type:
- Article
Humoral modulation of lymphokine-activated killer (LAK)-cell induction in humans: IgG-related and non-IgG inhibitors in sera from cancer patients.
- Published in:
- International Journal of Cancer, 1990, v. 46, n. 5, p. 785, doi. 10.1002/ijc.2910460506
- By:
- Publication type:
- Article
Polymorphism of the 5'-Flanking Region of the Tumor Necrosis Factor (TNF)-alpha Gene and...
- Published in:
- Journal of Infectious Diseases, 1999, v. 180, n. 3, p. 880, doi. 10.1086/314917
- By:
- Publication type:
- Article
Randomized clinical trial of an ethanol extract of Ganoderma lucidum in men with lower urinary tract symptoms.
- Published in:
- Asian Journal of Andrology, 2008, v. 10, n. 5, p. 777, doi. 10.1111/j.1745-7262.2008.00361.x
- By:
- Publication type:
- Article
Target molecules in specific immunotherapy against prostate cancer.
- Published in:
- International Journal of Clinical Oncology, 2003, v. 8, n. 4, p. 193, doi. 10.1007/s10147-003-0332-x
- By:
- Publication type:
- Article
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b<sup>+</sup> HLA-A24<sup>+</sup> patients.
- Published in:
- Hepatology Research, 2007, v. 37, n. 3, p. 186, doi. 10.1111/j.1872-034X.2007.00018.x
- By:
- Publication type:
- Article
Identification of hepatitis C virus 1b-derived peptides recognized by both cellular and humoral immune systems in HCV1b<sup>+</sup> HLA-A24<sup>+</sup> patients
- Published in:
- Hepatology Research, 2005, v. 32, n. 4, p. 227, doi. 10.1016/j.hepres.2005.06.003
- By:
- Publication type:
- Article
Feasibility Study of Personalized Peptide Vaccination for Advanced Small Cell Lung Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Detection of Circulating Tumor Cells in Patients with Prostate Cancer Using Prostate Specific Membrane-Derived Primers in the Polymerase Chain Reaction.
- Published in:
- International Journal of Urology, 1997, v. 4, n. 4, p. 374, doi. 10.1111/j.1442-2042.1997.tb00211.x
- By:
- Publication type:
- Article
Humoral Immune Responses to EGFR-Derived Peptides Predict Progression-Free and Overall Survival of Non-Small Cell Lung Cancer Patients Receiving Gefitinib.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0086667
- By:
- Publication type:
- Article
EGFR T790M Mutation as a Possible Target for Immunotherapy; Identification of HLA-A*0201-Restricted T Cell Epitopes Derived from the EGFR T790M Mutation.
- Published in:
- PLoS ONE, 2013, v. 8, n. 11, p. 1, doi. 10.1371/journal.pone.0078389
- By:
- Publication type:
- Article
High expression of APOBEC3G in patients infected with hepatitis C virus.
- Published in:
- Journal of Molecular Histology, 2006, v. 37, n. 8/9, p. 327, doi. 10.1007/s10735-006-9059-0
- By:
- Publication type:
- Article
Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity.
- Published in:
- 1983
- By:
- Publication type:
- journal article
Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine.
- Published in:
- Evidence-based Complementary & Alternative Medicine (eCAM), 2013, v. 2013, p. 1, doi. 10.1155/2013/981717
- By:
- Publication type:
- Article
Mixed 20-peptide cancer vaccine in combination with docetaxel and dexamethasone for castration-resistant prostate cancer: a randomized phase II trial.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 5, p. 847, doi. 10.1007/s00262-020-02498-8
- By:
- Publication type:
- Article
Immunological evaluation of personalized peptide vaccination for patients with histologically unfavorable carcinoma of unknown primary site.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 10, p. 1223, doi. 10.1007/s00262-016-1887-5
- By:
- Publication type:
- Article
A randomized phase II clinical trial of personalized peptide vaccination with metronomic low-dose cyclophosphamide in patients with metastatic castration-resistant prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2016, v. 65, n. 2, p. 151, doi. 10.1007/s00262-015-1781-6
- By:
- Publication type:
- Article
Haptoglobin promoter polymorphism rs5472 as a prognostic biomarker for peptide vaccine efficacy in castration-resistant prostate cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 12, p. 1565, doi. 10.1007/s00262-015-1756-7
- By:
- Publication type:
- Article
Phase I trial of a cancer vaccine consisting of 20 mixed peptides in patients with castration-resistant prostate cancer: dose-related immune boosting and suppression.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 493, doi. 10.1007/s00262-015-1660-1
- By:
- Publication type:
- Article
Personalized peptide vaccination: a new approach for advanced cancer as therapeutic cancer vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 919, doi. 10.1007/s00262-012-1379-1
- By:
- Publication type:
- Article
A randomized phase II trial of personalized peptide vaccine plus low dose estramustine phosphate (EMP) versus standard dose EMP in patients with castration resistant prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 7, p. 1001, doi. 10.1007/s00262-010-0822-4
- By:
- Publication type:
- Article
Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1845, doi. 10.1007/s00262-009-0695-6
- By:
- Publication type:
- Article
An HLA-A3-binding prostate acid phosphatase-derived peptide can induce CTLs restricted to HLA-A2 and -A24 alleles.
- Published in:
- Cancer Immunology, Immunotherapy, 2009, v. 58, n. 11, p. 1879, doi. 10.1007/s00262-009-0699-2
- By:
- Publication type:
- Article
A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 9, p. 1359, doi. 10.1007/s00262-007-0284-5
- By:
- Publication type:
- Article
Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles.
- Published in:
- Cancer Immunology, Immunotherapy, 2007, v. 56, n. 5, p. 689, doi. 10.1007/s00262-006-0216-9
- By:
- Publication type:
- Article
Identification of new prostate stem cell antigen-derived peptides immunogenic in HLA-A2<sup>+</sup> patients with hormone-refractory prostate cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2004, v. 53, n. 6, p. 479, doi. 10.1007/s00262-003-0464-x
- By:
- Publication type:
- Article
A simple culture protocol to detect peptide-specific cytotoxic T lymphocyte precursors in the circulation.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 4, p. 219, doi. 10.1007/s00262-002-0273-7
- By:
- Publication type:
- Article